China (Mainland)
Premiumsupplier
High Quality Peptide 98% Semaglutide CAS 782487-28-9 GLP-1 CAS NO.782487-28-9
- Min.Order: 1 Gram
- Payment Terms: T/T,MoneyGram
- Product Details
Keywords
- Semaglutide
- cas 782487-28-9
- Semaglutide powder
Quick Details
- ProName: High Quality Peptide 98% Semaglutide C...
- CasNo: 782487-28-9
- Molecular Formula: C187H291N45O59
- Appearance: white powder
- Application: used for the treatment of obesity
- DeliveryTime: within 3 working days upon payment
- PackAge: aluminum foil bag, discreet packing
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 10 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: EMS,DHL,HK post,EUB,ETK,NL post,German...
- LimitNum: 1 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
High Quality Peptide 98% Semaglutide CAS 782487-28-9 GLP-1
Product Introduction:
Product Name: Semaglutide
CAS No. :782487-28-9
Synonyms:semaglutide;AQX10;Rosiptor
Purity: 98% min
Testing Method: HPLC
Appearance: White powder
Semaglutide (USAN; trade name Ozempic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Ozempic. As aglucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production of insulin. It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDAapproval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.
Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment ofobesity. It reduces hunger, food craving and body fat.
|
Product Name |
CAS No. |
Purity |
|
Oxytocin |
50-56-6 |
99% |
|
Sermorelin |
86168-78-7 |
98% |
|
Teriparatide |
52232-67-4 |
98% |
|
Exenatide |
141732-76-5 |
98% |
|
Desmopressin |
16789-98-3 |
98% |
|
Triptorelin |
57773-63-4 |
98% |
|
Eptifibatide |
188627-80-7 |
98% |
|
Deslorelin |
57773-65-6 |
98% |
|
Ipamorelin |
170851-70-4 |
98% |
|
Leuprorelin |
74381-53-6 |
98% |
|
Lysipressin |
50-57-7 |
98% |
|
Cetrorelix |
120287-85-6 |
98% |
|
Atosiban |
90779-69-4 |
98% |
|
Liraglutide |
204656-20-2 |
98% |
|
GHRP-2 |
158861-67-7 |
98% |
|
Tetracosactide |
16960-16-0 |
98% |
|
GHRP-6 |
87616-84-0 |
98% |
|
Terlipressin |
14636-12-5 |
98% |
|
Alarelin |
79561-22-1 |
98% |
|
DSIP |
62568-57-4 |
98% |
|
Pramlintide |
196078-30-5 |
98% |
|
CJC-1295 (Without DAC) |
863288-34-0 |
98% |
|
Calcitonin Salmon |
47931-85-1 |
98% |
|
Pehtagastrin |
5534-95-2 |
98% |
|
Argipressin |
113-79-1 |
98% |
|
Met-Enkephaline |
58569-55-4 |
98% |
|
Glucagon |
16941-32-5 |
98% |
|
Octreotide |
83150-76-9 |
98% |
|
Gonadorelin |
71447-49-9 |
98% |
|
Somatostatin |
38916-34-6 |
98% |
|
Lecirelin |
61012-19-9 |
98% |
|
Thymulin |
63958-90-7 |
98% |
|
Semax |
80714-61-0 |
98% |
|
Selank |
129954-34-3 |
98% |
|
BPC 157 |
137525-51-0 |
98% |
|
Dihexa |
1401708-83-5 |
98% |
|
PACAP-38 |
137061-48-4 |
98% |
|
PACAP-27 |
127317-03-7 |
98% |
|
Semaglutide |
782487-28-9 |
98% |
|
Transdermal peptide |
- |
98% |
|
Indolicidin |
140896-21-5 |
98% |
Packing and shipping
